US FDA warnings target four drug companies (Reuters)

Reuters - The U.S. Food and Drug Administration has asked Bayer AG, Amylin Pharmaceuticals, Eli Lilly, and Cephalon to stop using "misleading" promotions for some drugs, according to letters released by the agency on Tuesday.